Johnson & Johnson
JNJ
#23
Rank
A$879.34 B
Marketcap
A$364.89
Share price
0.21%
Change (1 day)
43.45%
Change (1 year)

Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.

EPS for Johnson & Johnson (JNJ)

EPS in 2026 (TTM): A$12.87

According to Johnson & Johnson's latest financial reports the company's current EPS (TTM) is A$12.43. In 2025 the company made an earnings per share (EPS) of A$15.85 an increase over its 2024 EPS that were of A$9.52.

EPS history for Johnson & Johnson from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$12.87-18.81%
2025A$15.8566.46%
2024A$9.52-53.6%
2023A$20.53111.16%
2022A$9.72-13.84%
2021A$11.2841.81%
2020A$7.96-18.92%
2019A$9.8121.2%
2018A$8.101125.3%
2017A$0.66-92.23%
2016A$8.507.37%
2015A$7.92-4.16%
2014A$8.2618.1%
2013A$7.0024.88%
2012A$5.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$9.99-19.63%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.86-85.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.14-58.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$5.32-57.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$40.18 223.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.64-70.70%๐Ÿ‡ซ๐Ÿ‡ท France
Gilead Sciences
GILD
A$10.56-15.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
A$12.43-0.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$5.09-59.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.53-55.51%๐Ÿ‡ฌ๐Ÿ‡ง UK